Medical News

RSS

IPIT uses Affymetrix’s DMET Plus biomarker panel to expand the PGENI

Affymetrix, Inc. announced today that the Institute for Pharmacogenomics and Individualized Therapy (IPIT) at the University of North Carolina in Chapel Hill is using the company’s DMET™ Plus biomarker panel to expand the Pharmacogenetics for Every Nation Initiative (PGENI).

28 Oct 2009

Noncardiovascular mortality are rates higher in patients receiving dialysis

Compared to the general population, patients starting dialysis have an increased risk of death that is not attributable to a higher rate of death from cardiovascular causes, as previously thought, according to a study in the October 28 issue of JAMA.

28 Oct 2009

IFPA urges WHO to act on new insights on psoriasis to help millions of psoriasis patients

October 29 is World Psoriasis Day. Conceived by patients for patients, World Psoriasis Day is a truly global event focusing on the burden of living with psoriasis. There are more than 125 million people with psoriasis/psoriatic arthritis in the world. Psoriasis is a severe chronic inflammatory disease that effects all ages, genders, races and ethnicities.

28 Oct 2009

NCKU transfers microalgal docosahexaenoic acid production technology to Vedan Biotechnology

NCKU President, Academician Michael Ming-Chiao Lai, signed Technology Transfer Agreement in this morning with Mr. Tou-Hsiung Yang, Chairman of Vedan International (Holding) Ltd, witnessed by Vedan Biotechnology President Shih-An (Raymond) Yang and the inventor, Prof. Huey-Lang Yang of the NCKU Institute of Biotechnology.

28 Oct 2009

PPD plans to separate compound partnering business from CRO business; spin-off to result in independent public companies

PPD, Inc. today announced its board of directors has authorized management to proceed with preparations to spin off its compound partnering business from its core contract research organization, or CRO, business.

28 Oct 2009

RadMD offers tips for efficient use of medical imaging during clinical trial process

Lengthier cancer trials and new regulations have forced pharmaceutical companies to look for new ways to minimize costs and increase efficiency. As a result, the use of medical imaging, which is currently being used in 3000 clinical trials, has come to the forefront.

28 Oct 2009

New biotechnology research center launched by SHRO

The Sbarro Health Research Organization (SHRO), a nonprofit research facility located at Temple University, will dedicate a new state-of-the-art biotechnology research center on Tuesday, October 27th, at 2 p.m. SHRO is one of the top three international laboratories, based on number of publications as ranked by the Cell Cycle Registry,

28 Oct 2009

Scientific breakthrough to derive human parthenogenetic stem cell lines from unfertilized human eggs

International Stem Cell Corporation (OTCBB:ISCO) (www.internationalstemcell.com) and Reproductive Medicine Associates of New York (RMA of New York) have shown that immature, unfertilized human eggs can be used to create “parthenotes” from which human parthenogenetic stem cell lines may be derived. Immature eggs are normally discarded during standard in vitro fertilization (IVF) procedures due to their inability to create an embryo.

28 Oct 2009

Online weight management support for overweight teen girls and mothers

Professionals from the entertainment industry have teamed with leaders in obesity treatment to create the first web destinations that offer affordable and accessible weight management support to overweight teen girls and their mothers.

28 Oct 2009

Self-funded division of FBMC sold to First Service Administrators

First Service Administrators, Inc. (FSAI), a leading risk manager for the health care industry and mid- to large-sized public and private employers, announced it has acquired the self-funded division of Fringe Benefits Management Company (FBMC).

28 Oct 2009

NPC, PMC to explore comparative effectiveness research for effective health care treatments

As Congress continues its efforts to reform the health care system, the National Pharmaceutical Council (NPC) and the Personalized Medicine Coalition (PMC) will host a conference tomorrow to explore a key topic in the debate: using comparative effectiveness research (CER) to determine which health care treatments are most effective while improving the quality of patient care through personalized medicine.

28 Oct 2009

Shire receives European approval for FOSRENOL

Shire plc, the global specialty biopharmaceutical company, today announced it has received approval through the European Mutual Recognition Procedure for an extension to the current indication for FOSRENOL(R) (lanthanum carbonate), paving the way to make the non-calcium, non-resin phosphate binder available throughout the EU to control hyperphosphataemia in chronic kidney disease (CKD) patients who are not on dialysis with a serum phosphorus level greather than or equal to 1.78mmol/L (5.5mg/dL).

28 Oct 2009

Precision Antibody to develop antibodies for NCI's Clinical Proteomic Technologies for Cancer

Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.

28 Oct 2009

BC Children's Hospital Foundation names Eagle Point townhome as a "Super Community"

The Eagle Point townhome complex in Port Moody was named a Super Community by BC Children's Hospital Foundation. The Search for a Super Community program was launched on September 21 on Global BC TV.

28 Oct 2009

Helix Hearing Care Centre and RA Centre host Healthy Aging Day

Helix Hearing Care Centre, The Senior Citizens Council of Ottawa, and the RA Centre hosted a Healthy Aging Day on Monday, where a capacity crowd of golden agers gathered to find out more about healthy hearing.

28 Oct 2009

Rutgers scientist receives 2009 Gruber International Research Award

For the first time, it now is possible for researchers to peer into those internal processes in a rodent brain. Eva Pastalkova, a post-doctoral researcher at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark and her advisor, Professor Gy-rgy Buzsaki, have developed a method for studying internally generated brain activity in rats.

28 Oct 2009

Health assessment may have some influence on health behaviors, say researchers

With open enrollment now underway at many companies, employees will be making decisions about their health care coverage for 2010. As part of their health plan enrollment, they may be asked to complete a health questionnaire known as a health assessment.

28 Oct 2009

Vocera smartphone for hospital settings

Vocera Inc. today announced the first shipment of the Vocera smartphone, the newest addition to the Vocera system of wireless, instant communication products. The new device, in addition to supporting all of the Vocera system’s unique voice-driven features, works as a wireless telephone and offers advanced application support to deliver enhanced staff efficiency and expedited patient care.

28 Oct 2009

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

Orexigen® Therapeutics, Inc. today announced results from new intent to treat (ITT) analyses from the COR-I and COR-II Phase 3 trials of Contrave® (naltrexone SR/bupropion SR), the first of two late stage Orexigen candidates for the treatment of obesity. These data expand on top-line results announced in July and complement findings from a panel discussion on Saturday where the Company presented data on Contrave patients who completed 56 weeks of therapy.

28 Oct 2009

NBPF develops 'Safe 'til Stable' preventative care program for bipolar disorder patients

A major breakthrough in mental health has been developed, a cooperative venture between the National Bipolar Foundation and the MedicAlert Foundation; a preventative care program called "Safe 'til Stable." It provides vital medical information to emergency responders in time of need through our live 24-hour emergency response service.

28 Oct 2009

Medical News

IPIT uses Affymetrix’s DMET Plus biomarker panel to expand the PGENI

Noncardiovascular mortality are rates higher in patients receiving dialysis

IFPA urges WHO to act on new insights on psoriasis to help millions of psoriasis patients

NCKU transfers microalgal docosahexaenoic acid production technology to Vedan Biotechnology

PPD plans to separate compound partnering business from CRO business; spin-off to result in independent public companies

RadMD offers tips for efficient use of medical imaging during clinical trial process

New biotechnology research center launched by SHRO

Scientific breakthrough to derive human parthenogenetic stem cell lines from unfertilized human eggs

Online weight management support for overweight teen girls and mothers

Self-funded division of FBMC sold to First Service Administrators

NPC, PMC to explore comparative effectiveness research for effective health care treatments

Shire receives European approval for FOSRENOL

Precision Antibody to develop antibodies for NCI's Clinical Proteomic Technologies for Cancer

BC Children's Hospital Foundation names Eagle Point townhome as a "Super Community"

Helix Hearing Care Centre and RA Centre host Healthy Aging Day

Rutgers scientist receives 2009 Gruber International Research Award

Health assessment may have some influence on health behaviors, say researchers

Vocera smartphone for hospital settings

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

NBPF develops 'Safe 'til Stable' preventative care program for bipolar disorder patients

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News